Anticipated Contributions: Our study will be the first to combine risk-stratification and innovative technology to decrease morbidity and mortality, and improve healthcare efficiency. This study will create new knowledge regarding the role of prolonged live monitoring among high-risk syncope patients and application of device prior to ED discharge. As the monitoring is live, timely management of potentially life threatening arrhythmias is possible and can be applied to syncope patients not at risk for ventricular arrhythmia and hospitalized solely for cardiac monitoring. This will represent a paradigm shift as patients can now be monitored at home at a very low cost decreasing ED and hospital crowding. These devices will alleviate fears of occult arrhythmia and death and will improve patient outcomes.